Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01145001 · ClinicalTrials.gov registry record · NA

Enhancing a High School Based Smoking Cessation Program

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
154
Enrollment target

NCT01145001 is a NA study that has completed, run by Yale University. The registered enrollment target is 154 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01145001, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target

Study Summary

The purpose of this study is to examine the the efficacy of adjunctive nicotine replacement therapy when used in combination with the contingency management (CM) + cognitive behavioral therapy intervention. Subjects will be randomly assigned to receive either a nicotine transdermal patch or a placebo patch as well as being randomly assigned to receive either CM or no CM; all subjects will receive cognitive behavioral therapy. We hypothesize that that subjects receiving both active nicotine patch and CM will have higher rates of abstinence from tobacco than subjects in the other groups.

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Cognitive Behavioural Therapy
  • DRUG Nicotine Transdermal Patch

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2009-11
Est. Completion 2015-01
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01145001

The ClinicalTrials.gov registry entry for NCT01145001 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Contingency Management is the first listed.

NCT01145001 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01145001 about?

NCT01145001 is a clinical study titled "Enhancing a High School Based Smoking Cessation Program". The purpose of this study is to examine the the efficacy of adjunctive nicotine replacement therapy when used in combination with the contingency management (CM) + cognitive behavioral therapy intervention. Subjects will be randomly assigned to receive either a nicotine transdermal patch or a placeb...

What is the current status of trial NCT01145001?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2009-11. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01145001?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Cognitive Behavioural Therapy (BEHAVIORAL), Nicotine Transdermal Patch (DRUG).

Who is sponsoring clinical trial NCT01145001?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.